Dr. Richard A. Boothby, MD

Dr. Boothby practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Boothby's NPI, 1376548354, was assigned on June 16, 2005. Dr. Boothby graduated from USF Health Morsani College of Medicine in 1980. Dr. Boothby holds Virginia license 0101272965.

Dr. Boothby's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Boothby's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. The medical group on file is MCV Physicians. Dmand AI also links Dr. Boothby to 1 more group practice or clinic, 1 urgent care center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boothby practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Boothby's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Boothby is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Boothby's licenses on file in 6 states: Virginia, Florida, New York, Vermont, Pennsylvania and Georgia.

Dmand AI lists hysterectomy among the conditions Dr. Boothby treats.

CMS data shows 40 Medicare services from Dr. Boothby across 1 procedure code in 2023, all of them office visits, for 42 Medicare patients. Medicare paid $2,392 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Boothby in 2024. The largest group is 65 to 74, with 25 patients. 71% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boothby's median patient age at 69, with 100% women.

In 2024, Dr. Boothby wrote 24 Medicare Part D claims. 58% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $29 in total drug cost. In 2019, CMS named 89 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Boothby for performance year 2024, reported as part of a group. Dr. Boothby accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Boothby. The most frequent topics are Ovarian Neoplasms. Dr. Boothby has published most often in Gynecol Oncol. Dr. Boothby's most frequent co-authors are George Douglas Everett, MD, James Vincent Fiorica, MD and Edward C. Grendys, MD.

Dmand AI links Dr. Boothby to 3 clinical trials, 3 of them phase 3 studies. Conditions studied include Carcinosarcoma, Uterine Cervical Neoplasms and Neoplasms, Complex and Mixed.

CMS Open Payments shows 13 general payments to Dr. Boothby from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $204.

Dmand AI lists 3 awards for Dr. Boothby, most recently Top Doctors: Florida in 2000.

Dr. Boothby graduated from USF Health Morsani College of Medicine in 1980. Dr. Boothby is a member of American College of Obstetricians and Gynecologists and SLS.

Dr. Boothby is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.